TERLIPRESSIN ANS (Southern XP IP Pty Ltd)
Product name
TERLIPRESSIN ANS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
195 (255 working days)
Active ingredients
terlipressin acetate
Registration type
New generic medicine
Indication
TERLIPRESSIN SXP is indicated for the:
- treatment of bleeding oesophageal varices (BOV);
- treatment of patients with Type 1 hepatorenal syndrome (HRS) who are actively being considered for liver transplant.